Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Shugoshin: From a Perspective of Clinical Disorders

Version 1 : Received: 24 March 2021 / Approved: 25 March 2021 / Online: 25 March 2021 (15:31:59 CET)

How to cite: Kumar, R.; Agarwal, M. Shugoshin: From a Perspective of Clinical Disorders. Preprints 2021, 2021030638 (doi: 10.20944/preprints202103.0638.v1). Kumar, R.; Agarwal, M. Shugoshin: From a Perspective of Clinical Disorders. Preprints 2021, 2021030638 (doi: 10.20944/preprints202103.0638.v1).

Abstract

Proper and timely segregation of cellular genome is an important and a prime requirement of all cell division programmes. Mis-segregation of chromosomes and resulting aneuploidy leads to several clinical consequences. Over the years, shugoshin emerges as a key protein factor involved in the segregation of genetic material in dividing cells. Deletion or altered level of shugoshin is reported in several human malignancies, as a result, shugoshin now emerges as an important tumour associated gene and a possible target for cancer therapy. Apart from the role in cancer, recent studies also showed the involvement of shugoshin in several other clinical disorders. Through this review, we tried to highlight the clinical relevance of shugoshin.

Subject Areas

Shugoshin; tumor suppressor; cancer; oncogene; tumour associated gene

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.